AARON SIEGEL: Open Payments
NPI 1164821500 · BUDD LAKE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 46 payments from 15 companies in 2025. Trend: 2023 $264 · 2024 $913 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $124 |
| Novo Nordisk Inc | 6 | $103 |
| PFIZER INC. | 6 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Amgen Inc. | 4 | $67 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Exact Sciences Corporation | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
Products named: Kerendia, PAXLOVID, OTEZLA, ZORYVE, BREZTRI, FARXIGA, Wegovy, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
